Say hello to MassDevice +3, a bite-sized view of the top three med-tech stories of the day. This feature of MassDevice.com’s coverage highlights our 3 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
If you read nothing else today, make sure you’re still in the know with MassDevice +3.
3. ESC 2012: Renal denervation a “fountain of youth,” researchers say
Doctors and researchers at the European Society of Cardiology Conference crow about the potential benefits of renal denervation in restoring youth to stiffened arteries, treating hypertension and maybe even benefiting patients with heart failure.
2. Medical Device Companies: Medtech’s best/worst valued stocks
A comparison of asset values and share values for medical device companies from theMassDevice Big 100 database.
1. The weight loss pacemaker: MassDevice Q&A with EnteroMedics
EnteroMedics CEO Mark Knudson and CFO Greg Lea tell MassDevice.com about the company’s Maestro weight loss pacemaker and how a twist on neuromodulation may help patients eat less and feel full without anatomy-altering surgery.
